Vilin Bio Med Ltd

NSE: VILINBIO · Pharmaceuticals & Biotechnology · 19 announcements

Share price: ₹51.25
Market cap: ₹78.16 Cr
Revenue (annual): ₹42.26 Cr
Net profit (annual): ₹1.93 Cr
P/E (TTM): 40.5×Sector 47.3×
Promoter holding: 56.65%-2.92% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 3 Management Change 3 Other Announcement 2 Financial Results 2 Board Meeting Date 2 Annual General Meeting 2 Promoter Reclassification 1 Capital Structure Change 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Apr 2026 13:17 IST NSE

Capital Structure Change

Vilin Bio Med Capital Structure Change

Vilin Bio Med Limited has received trading approval from the National Stock Exchange for 13,00,000 equity shares of Rs.10/- each. These shares were issued on a preferential allotment basis. The approval facilitates the secondary market trading of these newly allotted securities.

Read the filing ↗